CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
saliva stimulationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05394090
NCT05394090N/ACompleted

The Role of Periodontal Diseases and Stimulation of Saliva Secretion in the Acute Phase of

Pomeranian Medical University Szczecin·interventional·Posted May 27, 2022·Updated May 27, 2022

In Brief

A clinical study evaluating saliva stimulation for Periodontal Diseases and 2 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Methods: 100 consecutive patients with their first ever ischemic stroke were enrolled in the study. 56 randomly selected patients were subjected to stimulation of salivation, the remaining patients were not stimulated. The severity of the neurological condition was assessed using the NIHSS scale on days 1, 3 and 7 of stroke. The incidence of periodontal diseases was classified using the Hall's scale in the 1st day of stroke. On days 1 and 7 of stroke, the concentration of IL-1beta, MMP8, OPG and RANKL in the patients' saliva was assessed using the Elisa technique. At the same time, the level of CRP and the number of leukocytes in the peripheral blood were tested on days 1, 3 and 7 of the stroke, and the incidence of upper respiratory and urinary tract infections was assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPoland
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 27, 2022
Enrollment StartJan 24, 2020
Primary CompletionApr 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.1 years ago

Interventions

saliva stimulationother

In 50 patients with ischemic stroke, saliva was the option of a neurologopedic massage of choice